Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Status update of Recordati's lercanidipine HCl

Aug. 9, 1996

SmithKline Beecham and Meiji Seika to comarket levcromakalim

Aug. 9, 1996

Eisai terminates E-4177 development

Aug. 9, 1996

Renin inhibitors described by Ciba-Geigy

Aug. 9, 1996

KRH-594: Wakunaga's angiotensin II antagonist

Aug. 9, 1996

Angiotensin II antagonists disclosed by Tanabe Seiyaku

Aug. 9, 1996

Alpha2-adrenoceptor agonists effective as cardiac arrest treatment

July 26, 1996

SR-140333 claimed as a cardioregulatory drug

July 26, 1996

BES and BENSPM claimed as vascular proliferative disorders treatment

July 26, 1996

Glaxo Wellcome claims GR-79236 for reducing myocardial injury

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...